Status:
COMPLETED
Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study is designed to evaluate the reproductibility and the performance of the 3 minutes sit-to-stand test in patients with idiopathic pulmonary fibrosis. To do this, the investigators are recrui...
Eligibility Criteria
Inclusion
- man or woman aged less than 85 years
- patients with Idiopathic Pulmonary Fibrosis without any acute exacerbation during 4 months before the inclusion
- Non-opposition to participation in research
- Patient with 6 minutes walk test \> 200 meters (with or without oxygen therapy)
Exclusion
- Patient with reduced locomotor activity, or joint pain that compromises the performance of the tests
- Patient with 6 minutes walk test \< 200 meters
- Patient with an other etiology of pulmonary fibrosis
- Other significant pulmonary diseases
- Patient with unstable cardiac disease
- Patient who may be, according to the investigator's assessment, not cooperating or respecting the obligations inherent in participating to the study.
- Opposition to participation in research
Key Trial Info
Start Date :
February 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03268915
Start Date
February 9 2017
End Date
December 9 2018
Last Update
August 8 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
La Tronche, France, 38700
2
Groupement Hospitalier Est
Lyon, France, 69677